मार्कसन्स फार्मा शेअर किंमत

मार्कसंस फार्मा इन्व्हेस्टमेंट रेटिंग

• मास्टर रेटिंग:

• मार्क्सन्स फार्मा लि. ही एक जागतिक फार्मास्युटिकल कंपनी आहे जी जेनेरिक औषधांचे संशोधन, विकास आणि उत्पादन करण्यात गुंतलेली आहे. हे औषधीय फॉर्म्युलेशनची विस्तृत श्रेणी ऑफर करते, प्रमुख उपचारात्मक क्षेत्रांना सेवा देते जसे की वेदना व्यवस्थापन, कार्डिओव्हॅस्क्युलर आणि गॅस्ट्रोइंटेस्टाइनल.

  Marksans Pharma has an operating revenue of Rs. 2,267.99 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 19% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 48% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 41 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

  डिस्कलेमर: हा स्टॉक विश्लेषण रिपोर्ट केवळ माहितीपूर्ण हेतूंसाठी अल्गोरिदमली तयार केला जातो आणि खरेदी किंवा विक्री शिफारस म्हणून विचारात घेतला जाऊ नये.